ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY

Similar documents
2017 Step Therapy Criteria

ALLERGIC CONJUNCTIVITIS AGENTS

ANTICONVULSANT STEP THERAPY

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

Step Therapy Requirements

ANTICONVULSANTS. Details

FirstCarolinaCare Insurance Company. Step Therapy Requirements

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

ANGIOTENSIN RECEPTOR BLOCKERS

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

Step Therapy Requirements. Effective: 05/01/2018

ANTIDIABETIC AGENTS - MISCELLANEOUS

Step Therapy Requirements. Effective: 11/01/2018

Step Therapy Requirements. Effective: 03/01/2015

ANTIDIABETIC AGENTS - MISCELLANEOUS

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

ANTIDIABETIC AGENTS - MISCELLANEOUS

Step Therapy Requirements. Effective: 1/1/2019

Step Therapy Medications

Simply Step Therapy Document September 2018 Y0114_18_33074_I_009

2019 PDP Basic Step Therapy Document

2019 Simply Step Therapy Document

Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

ACYCLOVIR OINT (CCHP2017)

2018 PDP Premier Step Therapy Document September 2018 Y0114_18_33144_I_009

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

ACYCLOVIR OINT (CCHP2017)

ACYCLOVIR OINT (CCHP2017)

ACYCLOVIR OINT (CCHP2017)

Step Therapy Requirements

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO) and Stride SM Value Rx Plus (HMO) Step Therapy Requirements

2015 Step Therapy Prior Authorization Medical Necessity Guidelines

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO), Stride SM Value Rx Plus (HMO) and Stride SM Gain Rx (HMO)

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir

ACYCLOVIR OINT (CCHP2017)

Step Therapy Criteria 2019

ALPHA GLUCOSIDASE INHIBITOR THERAPY

TEST ANTICONVULSANT THERAPY. Products Affected. Step 2: Network Health Insurance Corporation NetworkCares Step Therapy Criteria Last Updated 11/2018

Drugs That Require Step Therapy (ST) Step Therapy Medications

2018 Step Therapy Criteria

Step Therapy Requirements

ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria

2019 STEP THERAPY CRITERIA UCare Individual & Family Plans UCare Individual & Family Plans with Fairview

ANTICONVULSANT THERAPY

DPP4 INHIBITORS. Products Affected Step 2: Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Januvia 100 mg tablet Januvia 25 mg tablet

SelectHealth Advantage 2018 Step Therapy Criteria. Previous trial on at least ONE: Generic topical acne treatment. Previous trial on: alendronate

Mercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria

DPP4 INHIBITORS. Details. Step Therapy Criteria Health Alliance Plan 2019 Date Effective: 04/01/2019

ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019

Step Therapy Group Algorithm Steps

SelectHealth Advantage 2018 Step Therapy Criteria Previous trial on at least ONE: Generic topical acne treatment

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Farm Bureau Health Plans Date Effective: November 1, 2018.

2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+)

ATYPICAL ANTIPSYCHOTICS

Step Therapy Group. Atypical Antipsychotic Agents

ADHD STIMULANTS-S(SHC)

SelectHealth Advantage 2019 Step Therapy Criteria Previous trial on at least ONE: Generic topical acne treatment

FirstCarolinaCare Insurance Company Step Therapy Requirements

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Health Choice Generations 1 Tier Gold Effective Date: 11/01/2018.

Y0133_StepTherapyCriteria _C 10/18/18 Y0133_StepTherapyCriteria _C es 10/18/18

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Optima Tier Gold Formulary Date Effective: November 1, 2018.

ALPHA BLOCKERS. Products Affected. Details. Step 2: RAPAFLO 4 MG CAPSULE. Step 1: alfuzosin extended release tablet doxazosin tablet

ALZHEIMER'S DRUGS. Details. Step 2: Exelon Patch 13.3 mg/24 hour transdermal Exelon Patch 4.6 mg/24 hr transdermal

2018 Step Therapy FID 18088

ADHD STIMULANTS - SCORE

STEP THERAPY CRITERIA

ADHD STIMULANTS - SCORE

Step Therapy Criteria

2018 Step Therapy Criteria (List of Step Therapy Criteria)

**CRITERIA UNDER CMS REVIEW**

STEP THERAPY ALGORITHMS PUP Select Formulary

WELLCARE/ OHANA HEALTH PLAN 2015 STEP THERAPY CRITERIA (No Changes Made Since: 08/2015)

Step Therapy Requirements. Effective: 12/01/2016

ALBUTEROL - SCORE{XE "ALBUTEROL - SCORE"}

Cigna Drug and Biologic Coverage Policy

Transcription:

South Country Health Alliance 2017 Step Therapy Formulary ID: 17431 Last Updated: 10/20/2017 Effective Date: 11-01-2017 ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY BENICAR 20 MG BENICAR 40 MG BENICAR 5 MG BENICAR HCT 20 MG-12.5 MG BENICAR HCT 40 MG-12.5 MG BENICAR HCT 40 MG-25 MG Step 1: First line therapy should be irbesartan, irbesartan/hctz, or losartan, losartan/hctz or valsartan/valsartan hctz. Second line therapy should be Benicar/Benicar HCT. 1

ANTICONVULSANT STEP THERAPY APTIOM 200 MG APTIOM 400 MG APTIOM 600 MG APTIOM 800 MG FYCOMPA 0.5 MG/ML ORAL SUSPENSION FYCOMPA 10 MG FYCOMPA 12 MG FYCOMPA 2 MG FYCOMPA 4 MG FYCOMPA 6 MG FYCOMPA 8 MG POTIGA 200 MG POTIGA 300 MG POTIGA 400 MG POTIGA 50 MG SPRITAM 1,000 MG FOR ORAL SUSPENSION SPRITAM 250 MG FOR ORAL SUSPENSION SPRITAM 500 MG FOR ORAL SUSPENSION SPRITAM 750 MG FOR ORAL SUSPENSION VIMPAT 10 MG/ML ORAL SOLUTION VIMPAT 100 MG VIMPAT 150 MG VIMPAT 200 MG VIMPAT 50 MG Step 1: First line therapy should be trial of two of the following: carbamazepine, carbamazepine ER, divalproex sodium, divalproex sodium ER, gabapentin, lamotrigine, lamotrigine ER, levetiracetam, levetiracetam ER, oxcarbazepine, valproic acid, zonisamide, phenytoin, phenytoin ER, felbamate, ethosuxamide, topiramate, primidone, Dilantin, phenobarbital, Gabitril, or tiagabine. Once two of these agents have been tried, patients can receive therapy with Aptiom, Spritam, Fycompa, or Vimpat. 2

South Country Health Alliance 2017 Step Therapy Formulary ID: 17431 Last Updated: 10/20/2017 Effective Date: 11-01-2017 ANTIDEPRESSANT STEP THERAPY FETZIMA 120 MG CAPSULE,EXTENDED RELEASE FETZIMA 20 MG (2)-40 MG (26) CAPSULE,EXTENDED RELEASE,24 HR,DOSE PACK FETZIMA 20 MG CAPSULE,EXTENDED RELEASE FETZIMA 40 MG CAPSULE,EXTENDED RELEASE FETZIMA 80 MG CAPSULE,EXTENDED RELEASE TRINTELLIX 10 MG TRINTELLIX 20 MG TRINTELLIX 5 MG VIIBRYD 10 MG (7)-20 MG (23) S IN A DOSE PACK VIIBRYD 10 MG VIIBRYD 20 MG VIIBRYD 40 MG Step 1: First line therapy should a documented trial of two of the following: citalopram, duloxetine, escitalopram, fluoxetine, paroxetine, sertraline, venlafaxine, venlafaxine ER. Once citalopram, duloxetine, escitalopram, fluoxetine, paroxetine, sertraline, venlafaxine or venlafaxine ER has been tried, patient can receive therapy with Trintellix, Fetzima or Viibryd. 3

ANTIPSYCHOTIC STEP THERAPY FANAPT 1 MG FANAPT 10 MG FANAPT 12 MG FANAPT 1MG(2)-2 MG(2)-4MG(2)-6 MG(2) S IN A DOSE PACK FANAPT 2 MG FANAPT 4 MG FANAPT 6 MG FANAPT 8 MG LATUDA 120 MG LATUDA 20 MG LATUDA 40 MG LATUDA 60 MG LATUDA 80 MG Step 1: First line therapy should be risperidone, risperidone ODT, olanzapine, olanzapine ODT, quetiapine or ziprasidone AND aripiprazole. Once risperidone, risperidone ODT, olanzapine, olanzapine ODT, quetiapine or ziprasidone AND aripiprazole has been tried, patients can receive therapy with Latuda or Fanapt. 4

South Country Health Alliance 2017 Step Therapy Formulary ID: 17431 Last Updated: 10/20/2017 Effective Date: 11-01-2017 AZOPT STEP THERAPY AZOPT 1 % EYE DROPS,SUSPENSION Step 1: First line therapy should be dorzolamide or dorzolamide/timolol. Once dorzolamide or dorzolamide/timolol has been tried, the patient can receive therapy with Azopt. 5

CALCIUM CHANNEL BLOCKERS STEP THERAPY afeditab cr 30 mg tablet,extended release afeditab cr 60 mg tablet,extended release isradipine 2.5 mg capsule isradipine 5 mg capsule nifedical xl 30 mg tablet,extended release nifedical xl 60 mg tablet,extended release nifedipine er 30 mg tablet,extended release nifedipine er 30 mg tablet,extended release 24 hr nifedipine er 60 mg tablet,extended release nifedipine er 60 mg tablet,extended release 24 hr nifedipine er 90 mg tablet,extended release nifedipine er 90 mg tablet,extended release 24 hr Step 1: First line therapy should be felodipine or amlodipine. Once felodipine or amlodipine have been tried, patients can receive therapy with nifedipine ER or isradipine. 6

South Country Health Alliance 2017 Step Therapy Formulary ID: 17431 Last Updated: 10/20/2017 Effective Date: 11-01-2017 CLOBETASOL 0.05% GEL AND OINTMENT STEP THERAPY clobetasol 0.05 % topical gel clobetasol 0.05 % topical ointment Step 1: First line therapy should be betamethasone dipropionate augmented gel and ointment or halobetasol cream and ointment. Step 2: Once betamethasone dipropionate augmented gel and ointment or halobetasol cream and ointment has been tried, patients can receive therapy with clobetasol 0.05% ointment or clobetasol 0.05% gel. 7

COMBIVENT STEP THERAPY COMBIVENT RESPIMAT 20 MCG- 100 MCG/ACTUATION SOLUTION FOR INHALATION Step 1: First line therapy should be Anoro Ellipta. Once Anoro Ellipta has been tried, patients can receive therapy with Combivent Respimat. 8

South Country Health Alliance 2017 Step Therapy Formulary ID: 17431 Last Updated: 10/20/2017 Effective Date: 11-01-2017 HYPOGLYCEMICS STEP THERAPY acarbose 100 mg tablet acarbose 25 mg tablet acarbose 50 mg tablet AVANDIA 2 MG AVANDIA 4 MG GLYXAMBI 10 MG-5 MG GLYXAMBI 25 MG-5 MG INVOKAMET 150 MG-1,000 MG INVOKAMET 150 MG-500 MG INVOKAMET 50 MG-1,000 MG INVOKAMET 50 MG-500 MG INVOKAMET XR 150 MG-1,000 MG, EXTENDED RELEASE INVOKAMET XR 150 MG-500 MG, EXTENDED RELEASE INVOKAMET XR 50 MG-1,000 MG, EXTENDED RELEASE INVOKAMET XR 50 MG-500 MG, EXTENDED RELEASE INVOKANA 100 MG INVOKANA 300 MG JANUMET 50 MG-1,000 MG JANUMET 50 MG-500 MG JANUMET XR 100 MG-1,000 MG,EXTENDED RELEASE JANUMET XR 50 MG-1,000 MG,EXTENDED RELEASE JANUMET XR 50 MG-500 MG,EXTENDED RELEASE JANUVIA 100 MG JANUVIA 25 MG JANUVIA 50 MG JARDIANCE 10 MG JARDIANCE 25 MG JENTADUETO 2.5 MG-1,000 MG JENTADUETO 2.5 MG-500 MG JENTADUETO 2.5 MG-850 MG JENTADUETO XR 2.5 MG-1,000 MG, EXTENDED RELEASE JENTADUETO XR 5 MG-1,000 MG, EXTENDED RELEASE nateglinide 120 mg tablet nateglinide 60 mg tablet repaglinide 0.5 mg tablet repaglinide 1 mg tablet repaglinide 2 mg tablet SYNJARDY 12.5 MG-1,000 MG SYNJARDY 12.5 MG-500 MG SYNJARDY 5 MG-1,000 MG SYNJARDY 5 MG-500 MG TRADJENTA 5 MG Step 1: First line therapy should be a formulary sulfonylurea, metformin, or formulary insulin (if appropriate). Once one of these agents has been tried, patients can receive therapy with other 9

10 formulary hypoglycemics such as Avandia, Acarbose, Januvia, Janumet, Janumet XR, repaglinide, nateglinide, Tradjenta, Jentadueto,Jentadueto XR, Invokana, Invokamet, Invokamet XR, Jardiance, Synjardy, or Glyxambi.

South Country Health Alliance 2017 Step Therapy Formulary ID: 17431 Last Updated: 10/20/2017 Effective Date: 11-01-2017 MYRBETRIQ STEP THERAPY tolterodine 1 mg tablet tolterodine 2 mg tablet Step 3: MYRBETRIQ 25 MG,EXTENDED RELEASE tolterodine er 2 mg capsule,extended release 24 hr tolterodine er 4 mg capsule,extended release 24 hr MYRBETRIQ 50 MG,EXTENDED RELEASE Step 1: First line therapy should be Oxybutynin or Oxybutynin ER. Second line therapy should be Tolterodine or Tolterodine ER. Step 3: Once Oxybutynin or Oxybutynin ER AND Tolterodine or Tolterodine ER has been tried, patients can receive therapy with Myrbetriq. 11

NAMENDA XR STEP THERAPY NAMENDA XR 14 MG CAPSULE SPRINKLE,EXTENDED RELEASE NAMENDA XR 21 MG CAPSULE SPRINKLE,EXTENDED RELEASE NAMENDA XR 28 MG CAPSULE SPRINKLE,EXTENDED RELEASE NAMENDA XR 7 MG CAPSULE SPRINKLE,EXTENDED RELEASE NAMENDA XR 7 MG-14 MG-21 MG- 28 MG CAPSULE,SPRINKLE,ER 24HR,DOSE PACK Step 1: First line therapy should be memantine tablet. Once memantine tablet has been tried, patients can receive therapy with Namenda XR. 12

South Country Health Alliance 2017 Step Therapy Formulary ID: 17431 Last Updated: 10/20/2017 Effective Date: 11-01-2017 OPHTHALMIC ANTIHISTAMINES STEP THERAPY olopatadine 0.1 % eye drops OTCs: ALAWAY, KETOTIFEN FUMARATE, ZADITOR. Step 1: First line therapy should be Zaditor OTC, ketotifen OTC or Alaway OTC. Second line therapy should be generic Olopatadine Ophthalmic Soln. 13

TOPICAL IMMUNOMODULATORS STEP THERAPY ELIDEL 1 % TOPICAL CREAM tacrolimus 0.03 % topical ointment tacrolimus 0.1 % topical ointment Step 1: First line therapy should be trial of 2 formulary topical corticosteroids. Once two of these agents have been tried, patients can receive therapy with Elidel or generic topical Tacrolimus. 14

South Country Health Alliance 2017 Step Therapy Formulary ID: 17431 Last Updated: 10/20/2017 Effective Date: 11-01-2017 TOPICAL TESTOSTERONE STEP THERAPY ANDROGEL 1.62 % (20.25 MG/1.25 GRAM) TRANSDERMAL GEL PACKET ANDROGEL 1.62 % (40.5 MG/2.5 GRAM) TRANSDERMAL GEL PACKET TESTIM 50 MG/5 GRAM (1 %) TRANSDERMAL GEL Step 1: Patient must try a generic topical testosterone product. Once a generic topical testosterone product has been tried, patients can receive therapy with AndroGel or Testim. 15

ULORIC STEP THERAPY ULORIC 40 MG ULORIC 80 MG Step 1: First line therapy should be allopurinol tablet. Once allopurinol tablet has been tried, patients can receive therapy with Uloric. 16

South Country Health Alliance 2017 Step Therapy Formulary ID: 17431 Last Updated: 10/20/2017 Effective Date: 11-01-2017 VRAYLAR STEP THERAPY VRAYLAR 1.5 MG (1)-3 MG (6) CAPSULES IN A DOSE PACK VRAYLAR 1.5 MG CAPSULE VRAYLAR 3 MG CAPSULE VRAYLAR 4.5 MG CAPSULE VRAYLAR 6 MG CAPSULE Step 1: First line therapy should be risperidone, risperidone ODT,olanzapine, olanzapine ODT or ziprasidone AND aripiprazolestep 2: Once risperidone, risperidone ODT, olanzapine, olanzapineodt or ziprasidone AND aripiprazole has been tried, patients canreceive therapy with Vraylar. 17

ZIRGAN STEP THERAPY ZIRGAN 0.15 % EYE GEL Step 1: First line therapy should be generic trifluridine ophthalmic Step 2: Once generic trifluridine ophthalmic has been tried, patients can receive therapy with Zirgan. 18

South Country Health Alliance 2017 Step Therapy Formulary ID: 17431 Last Updated: 10/20/2017 Effective Date: 11-01-2017 ZORVOLEX STEP THERAPY ZORVOLEX 18 MG CAPSULE ZORVOLEX 35 MG CAPSULE Step 1: First line therapy must be trial of 1 formulary non-selective NSAID. Once one of these agents have been tried patients can receive therapy with Zorvolex. 19

Index A acarbose 100 mg tablet... 9 acarbose 25 mg tablet... 9 acarbose 50 mg tablet... 9 afeditab cr 30 mg tablet,extended release... 6 afeditab cr 60 mg tablet,extended release... 6 ANDROGEL 1.62 % (20.25 MG/1.25 GRAM) TRANSDERMAL GEL PACKET... 15 ANDROGEL 1.62 % (40.5 MG/2.5 GRAM) TRANSDERMAL GEL PACKET... 15 APTIOM 200 MG... 2 APTIOM 400 MG... 2 APTIOM 600 MG... 2 APTIOM 800 MG... 2 AVANDIA 2 MG... 9 AVANDIA 4 MG... 9 AZOPT 1 % EYE DROPS,SUSPENSION 5 B BENICAR 20 MG... 1 BENICAR 40 MG... 1 BENICAR 5 MG... 1 BENICAR HCT 20 MG-12.5 MG... 1 BENICAR HCT 40 MG-12.5 MG... 1 BENICAR HCT 40 MG-25 MG 1 C clobetasol 0.05 % topical gel... 7 clobetasol 0.05 % topical ointment... 7 COMBIVENT RESPIMAT 20 MCG-100 MCG/ACTUATION SOLUTION FOR INHALATION... 8 E ELIDEL 1 % TOPICAL CREAM... 14 F FANAPT 1 MG... 4 FANAPT 10 MG... 4 FANAPT 12 MG... 4 FANAPT 1MG(2)-2 MG(2)-4MG(2)-6 MG(2) S IN A DOSE PACK... 4 FANAPT 2 MG... 4 FANAPT 4 MG... 4 FANAPT 6 MG... 4 FANAPT 8 MG... 4 FETZIMA 120 MG CAPSULE,EXTENDED RELEASE... 3 FETZIMA 20 MG (2)-40 MG (26) CAPSULE,EXTENDED RELEASE,24 HR,DOSE PACK... 3 FETZIMA 20 MG CAPSULE,EXTENDED RELEASE... 3 FETZIMA 40 MG CAPSULE,EXTENDED RELEASE... 3 FETZIMA 80 MG CAPSULE,EXTENDED RELEASE... 3 FYCOMPA 0.5 MG/ML ORAL SUSPENSION... 2 FYCOMPA 10 MG... 2 FYCOMPA 12 MG... 2 FYCOMPA 2 MG... 2 FYCOMPA 4 MG... 2 FYCOMPA 6 MG... 2 FYCOMPA 8 MG... 2 G GLYXAMBI 10 MG-5 MG... 9 GLYXAMBI 25 MG-5 MG... 9 I INVOKAMET 150 MG-1,000 MG... 9 INVOKAMET 150 MG-500 MG 9 INVOKAMET 50 MG-1,000 MG... 9 INVOKAMET 50 MG-500 MG. 9 INVOKAMET XR 150 MG-1,000 MG, EXTENDED RELEASE... 9 INVOKAMET XR 150 MG-500 MG, EXTENDED RELEASE... 9 INVOKAMET XR 50 MG-1,000 MG, EXTENDED RELEASE... 9 INVOKAMET XR 50 MG-500 MG, EXTENDED RELEASE... 9 INVOKANA 100 MG... 9 INVOKANA 300 MG... 9 isradipine 2.5 mg capsule... 6 isradipine 5 mg capsule... 6 J JANUMET 50 MG-1,000 MG... 9 20

South Country Health Alliance 2017 Step Therapy Formulary ID: 17431 Last Updated: 10/20/2017 Effective Date: 11-01-2017 JANUMET 50 MG-500 MG... 9 JANUMET XR 100 MG-1,000 MG,EXTENDED RELEASE... 9 JANUMET XR 50 MG-1,000 MG,EXTENDED RELEASE... 9 JANUMET XR 50 MG-500 MG,EXTENDED RELEASE... 9 JANUVIA 100 MG... 9 JANUVIA 25 MG... 9 JANUVIA 50 MG... 9 JARDIANCE 10 MG... 9 JARDIANCE 25 MG... 9 JENTADUETO 2.5 MG-1,000 MG... 9 JENTADUETO 2.5 MG-500 MG... 9 JENTADUETO 2.5 MG-850 MG... 9 JENTADUETO XR 2.5 MG-1,000 MG, EXTENDED RELEASE... 9 JENTADUETO XR 5 MG-1,000 MG, EXTENDED RELEASE... 9 L LATUDA 120 MG... 4 LATUDA 20 MG... 4 LATUDA 40 MG... 4 LATUDA 60 MG... 4 LATUDA 80 MG... 4 M MYRBETRIQ 25 MG,EXTENDED RELEASE... 11 MYRBETRIQ 50 MG,EXTENDED RELEASE... 11 N NAMENDA XR 14 MG CAPSULE SPRINKLE,EXTENDED RELEASE... 12 NAMENDA XR 21 MG CAPSULE SPRINKLE,EXTENDED RELEASE... 12 NAMENDA XR 28 MG CAPSULE SPRINKLE,EXTENDED RELEASE... 12 NAMENDA XR 7 MG CAPSULE SPRINKLE,EXTENDED RELEASE... 12 NAMENDA XR 7 MG-14 MG-21 MG-28 MG CAPSULE,SPRINKLE,ER 24HR,DOSE PACK... 12 nateglinide 120 mg tablet... 9 nateglinide 60 mg tablet... 9 nifedical xl 30 mg tablet,extended release.. 6 nifedical xl 60 mg tablet,extended release.. 6 nifedipine er 30 mg tablet,extended release 6 nifedipine er 30 mg tablet,extended release 24 hr... 6 nifedipine er 60 mg tablet,extended release 6 nifedipine er 60 mg tablet,extended release 24 hr... 6 nifedipine er 90 mg tablet,extended release 6 nifedipine er 90 mg tablet,extended release 24 hr... 6 O olopatadine 0.1 % eye drops... 13 P POTIGA 200 MG... 2 POTIGA 300 MG... 2 POTIGA 400 MG... 2 POTIGA 50 MG... 2 R repaglinide 0.5 mg tablet... 9 repaglinide 1 mg tablet... 9 repaglinide 2 mg tablet... 9 S SPRITAM 1,000 MG FOR ORAL SUSPENSION... 2 SPRITAM 250 MG FOR ORAL SUSPENSION... 2 SPRITAM 500 MG FOR ORAL SUSPENSION... 2 SPRITAM 750 MG FOR ORAL SUSPENSION... 2 SYNJARDY 12.5 MG-1,000 MG... 9 SYNJARDY 12.5 MG-500 MG. 9 SYNJARDY 5 MG-1,000 MG... 9 SYNJARDY 5 MG-500 MG... 9 T tacrolimus 0.03 % topical ointment... 14 21

tacrolimus 0.1 % topical ointment... 14 TESTIM 50 MG/5 GRAM (1 %) TRANSDERMAL GEL... 15 tolterodine 1 mg tablet... 11 tolterodine 2 mg tablet... 11 tolterodine er 2 mg capsule,extended release 24 hr... 11 tolterodine er 4 mg capsule,extended release 24 hr... 11 TRADJENTA 5 MG... 9 TRINTELLIX 10 MG... 3 TRINTELLIX 20 MG... 3 TRINTELLIX 5 MG... 3 U ULORIC 40 MG... 16 ULORIC 80 MG... 16 V VIIBRYD 10 MG (7)-20 MG (23) S IN A DOSE PACK... 3 VIIBRYD 10 MG... 3 VIIBRYD 20 MG... 3 VIIBRYD 40 MG... 3 VIMPAT 10 MG/ML ORAL SOLUTION. 2 VIMPAT 100 MG... 2 VIMPAT 150 MG... 2 VIMPAT 200 MG... 2 VIMPAT 50 MG... 2 VRAYLAR 1.5 MG (1)-3 MG (6) CAPSULES IN A DOSE PACK... 17 VRAYLAR 1.5 MG CAPSULE... 17 VRAYLAR 3 MG CAPSULE... 17 VRAYLAR 4.5 MG CAPSULE... 17 VRAYLAR 6 MG CAPSULE... 17 Z ZIRGAN 0.15 % EYE GEL... 18 ZORVOLEX 18 MG CAPSULE... 19 ZORVOLEX 35 MG CAPSULE... 19 22